Manufacturer Quantity Restrictions and Generic vs Brand Name Lenalidomide Use Among Insured Patients
Year: 2026
Type: article
Study design: Observational Study
Abstract: This cohort study assesses patients’ use of brand-name and generic lenalidomide following the first generic market entrant in March 2022.
Source: JAMA Network Open
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $3,000
OpenAlex ID: W7235375417
